60
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis

, , , , , , , , & show all
Pages 5551-5559 | Published online: 22 Nov 2017

References

  • JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
  • KnowlesMAHurstCDMolecular biology of bladder cancer: new insights into pathogenesis and clinical diversityNature Reviews Cancer2015151254125533674
  • YafiFAAprikianAGChinJLContemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experienceBJU Int2011108453954521166753
  • NargundVHTanabalanCKKabirMNManagement of non-muscle-invasive (superficial) bladder cancerSemin Oncol201239555957223040252
  • ShelleyMDMasonMDKynastonHIntravesical therapy for superficial bladder cancer: A systematic review of randomised trials and meta-analysesCancer Treat Rev201036319520520079574
  • WilsonRCDoudnaJAMolecular mechanisms of RNA interferenceAnnu Rev Biophys20134221723923654304
  • KentOAMendellJTA small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenesOncogene20062546618817028598
  • RaskLBalslevESøkildeRDifferential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node statusCell Oncol (Dordr)201437321522725027758
  • ZhaoTRenHLiJLASP1 is a HIF1α target gene critical for metastasis of pancreatic cancerCancer Res201575111111925385028
  • GuXFuCLinLmiR-124 and miR-9 mediated downregulation of HDAC5 promotes neurite development through activating MEF2C-GPM6A pathwayJ Cell Physiol2017233167368728332716
  • DuYYZhaoLMChenLThe tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinomaJ Gastroenterol Hepatol201631238439326414725
  • DraytonRMDudziecEPeterSReduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11Clin Cancer Res20142071990200024516043
  • EissaSHabibHAliEKotbYEvaluation of urinary miRNA-96 as a potential biomarker for bladder cancer diagnosisMed Oncol201532117
  • HirataHUenoKShahryariVOncogenic miRNA-182–5p Targets Smad4 and RECK in Human Bladder CancerPLoS One2012711e5105623226455
  • YuHPeiDChenLZhouXZhuHIdentification of key genes and molecular mechanisms associated with dedifferentiated liposarcoma based on bioinformatic methodsOncoTargets Ther20171030173027
  • KangLTaoXHeBSMicroRNA expression profiles predict progression and clinical outcome in lung adenocarcinomaOnco Targets Ther201695679569227695346
  • GiuliettiMOcchipintiGPrincipatoGPivaFIdentification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysisCell Oncol (Dordr)201740218119228205147
  • VoineaguIWangXJohnstonPTranscriptomic analysis of autistic brain reveals convergent molecular pathologyNature2011474735138038421614001
  • National Institutes of HealthThe Cancer Genome Atlas Available from: https://cancergenome.nih.gov/Accessed March 23, 2017
  • RobinsonMDMccarthyDJSmythGKedgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics201026113914019910308
  • LangfelderPHorvathSWGCNA: an R package for weighted correlation network analysisBMC Bioinformatics2008955919114008
  • DupuisJGeometric interpretation of gene coexpression network analysisPLoS Comput Biol200848e100011718704157
  • YipAMHorvathSGene network interconnectedness and the generalized topological overlap measureBMC Bioinformatics200782217250769
  • LangfelderPLuoROldhamMCHorvathSIs my network module preserved and reproducible?PLoS Comput Biol201171e100105721283776
  • LangfelderPHorvathSEigengene networks for studying the relationships between co-expression modulesBMC Syst Biol2007115418031580
  • DeweyFEPerezMVWheelerMTGene coexpression network topology of cardiac development, hypertrophy, and failureCirc Cardiovascu Genet2011412635
  • AgarwalVBellGWNamJWBartelDPPredicting effective microRNA target sites in mammalian mRNAseLife20154e05005
  • UhlenMOksvoldPFagerbergLTowards a knowledge-based Human Protein AtlasNat Biotechnol201028121248125021139605
  • ShannonPMarkielAOzierOCytoscape: a software environment for integrated models of biomolecular interaction networksGenome Res200313112498250414597658
  • YamasakiTYoshinoHEnokidaHMolecular targets regulated by tumor suppressive microRNA-1 and microRNA-133a in bladder cancerInt J Oncol20124061821183022378464
  • KawakamiKEnokidaHChiyomaruTThe functional significance of miR-1 and miR-133a in renal cell carcinomaEur J Cancer201248682783621745735
  • PatronJPFendlerABildMMiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosisPLoS One201274e3534522532850
  • KaraMYumrutasOOzcanODifferential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinomaGene20155671818625925209
  • LiuBQuJXuFMiR-195 suppresses non-small cell lung cancer by targeting CHEK1Oncotarget20156119445945625840419
  • AlmeidaMINicolosoMSZengLStrand-specific miR-28–5p and miR-28–3p have distinct effects in colorectal cancer cellsGastroenterology2012142488689622240480
  • GomesSESimõesAESPereiraDMCastroRERodriguesCMPBorralhoPMmiR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cellsOncotarget2016789368938726824186
  • BurottoMChiouVLLeeJMKohnECThe MAPK pathway across different malignancies: a new perspectiveCancer2014120223446345624948110
  • KimEKChoiEJCompromised MAPK signaling in human diseases: an updateArch Toxicol201589686788225690731
  • XuLZhangYWangHZhangGDingYZhaoLTumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K/AKT pathwayJ Transl Med201412111224387290
  • WangHAnHWangBmiR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathwayEur J Cancer201349183924393523968734
  • LiuWLiCXuYTopologically inferring risk-active pathways toward precise cancer classification by directed random walkBioinformatics201329172169217723842813
  • YamaguchiHCondeelisJRegulation of the actin cytoskeleton in cancer cell migration and invasionBiochim Biophys Acta20071773564265216926057
  • LiDHuJSongHmiR-143–3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cellsAm J Transl Res2017952276228528559978
  • LiuRYangMMengYTumor-suppressive function of miR-139–5p in esophageal squamous cell carcinomaPLoS One2013810e7706824204738
  • EldeiryWSTokinoTVelculescuVEWAF1, a potential mediator of p53 tumor suppressionCell19937548178258242752
  • LevineAJMomandJFinlayCAThe p53 tumour suppressor geneNature19983516326453456
  • SachdevaMZhuSWuFp53 represses c-Myc through induction of the tumor suppressor miR-145Proc Natl Acad Sci U S A200910693207321219202062
  • CharfiCEdouardERassartEIdentification of GPM6A and GPM6B as potential new human lymphoid leukemia-associated oncogenesCell Oncol (Dordr)201437317919124916915